Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (Weighted Average): 2010-2021

Historic Shares Outstanding (Weighted Average) for Neurocrine Biosciences (NBIX) over the last 12 years, with Sep 2021 value amounting to $94.6 million.

  • Neurocrine Biosciences' Shares Outstanding (Weighted Average) rose 1.49% to $94.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $94.6 million, marking a year-over-year increase of 1.49%. This contributed to the annual value of $93.4 million for FY2020, which is 1.45% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Shares Outstanding (Weighted Average) stood at $94.6 million, which was up 0.11% from $94.5 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Weighted Average) peaked at $94.6 million during Q3 2021, and registered a low of $87.1 million during Q1 2017.
  • Over the past 3 years, Neurocrine Biosciences' median Shares Outstanding (Weighted Average) value was $92.9 million (recorded in 2020), while the average stood at $92.8 million.
  • Data for Neurocrine Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY increased of 2.55% (in 2018) over the last 5 years.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Shares Outstanding (Weighted Average) stood at $88.5 million in 2017, then grew by 2.47% to $90.7 million in 2018, then grew by 1.56% to $92.1 million in 2019, then climbed by 1.45% to $93.4 million in 2020, then rose by 1.49% to $94.6 million in 2021.
  • Its Shares Outstanding (Weighted Average) was $94.6 million in Q3 2021, compared to $94.5 million in Q2 2021 and $93.9 million in Q1 2021.